Statistics on Biotechnology Use  
Results by fields of operation
Company sector.  Biotechnology results by main variables by whichever Biotechnology activities are the main ones, secondary or a tool necessary for production
Unidades: specified in variables

,Total,Main,Secondary dwellings,Tool,
Companies that carry out R&D in Biotechnology,1.233,615,178,440,
%Companies according to biotechnology used: Genetic code,31,7,40,8,21,9,22,8,
%Companies according to biotechnology used: Functional units,38,5,45,5,38,3,28,8,
%Companies according to biotechnology used: Cellular and tissue culturing and engineering,22,8,28,2,21,2,15,7,
%Companies according to biotechnology used: Bioprocesses,53,4,46,9,57,3,60,8,
%Companies according to biotechnology used: Sub-cellular organisms,8,6,12,5,5,2,4,6,
%Companies according to biotechnology used: Bio-computing,22,3,31,7,15,1,12,
%Companies according to biotechnology used: Nanobiotechnology,10,6,13,9,15,2,4,3,
%Companies according to biotechnology used: Other,14,2,14,8,17,1,12,2,
%Company by field(s) of ultimate application of biotechnology use: Human Health,46,3,63,37,1,26,6,
%Company by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture,16,2,19,7,16,9,11,2,
%Company by field(s) of ultimate application of biotechnology use: Food products,32,24,2,29,9,43,9,
%Company by field(s) of ultimate application of biotechnology use: Agriculture and forest production,24,6,22,5,30,1,25,3,
%Company by field(s) of ultimate application of biotechnology use: Environment,15,5,13,7,26,8,13,4,
%Company by field(s) of ultimate application of biotechnology use: Industry,12,9,14,3,22,6,6,9,
Personnel in R&D in biotechnology (no. of persons),13.444,7.243,1.822,4.379,
Personnel in R&D in biotechnology (no. of persons): Researchers,7.378,4.139,1.032,2.207,
Personnel in R&D in biotechnology (no. of persons): Technicians and assistants,6.066,3.105,790,2.171,
Personnel in R&D in biotechnology (no. of persons): women,7.501,4.255,917,2.329,
Personnel in R&D in biotechnology (no. of persons): (women) Researchers,4.052,2.352,542,1.158,
Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants,3.450,1.903,376,1.171,
Personnel in R&D in biotechnology (FTE),9.401,9,5.696,8,1.025,3,2.679,9,
Personnel in R&D in biotechnology (FTE): Researchers,5.398,3,3.332,7,675,7,1.389,9,
Personnel in R&D in biotechnology (FTE): Technicians and assistants,4.003,6,2.364,1,349,5,1.290,
Personnel in R&D in biotechnology (FTE): women,5.426,2,3.428,5,556,8,1.440,9,
Personnel in R&D in biotechnology (FTE): (women) Researchers,3.016,4,1.924,6,360,1,731,7,
Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants,2.409,8,1.503,9,196,7,709,2,
Internal expenditure on R&D (thousands of euros),897.333,602.520,77.601,217.211,
1) By nature of the expense: Current expenses,817.409,541.269,71.986,204.154,
1.1) Remuneration to researchers,295.705,194.401,32.922,68.382,
1.2) Remuneration to technicians and assistants,156.853,98.937,11.856,46.060,
1.3) Other current expenses,364.852,247.931,27.209,89.712,
2) By nature of the expense: Capital expenses,79.924,61.251,5.615,13.057,
2.1) Land and buildings,10.272,8.482,898,892,
2.2) Equipment and instruments,56.609,41.244,4.323,11.043,
2.3) Acquisition of specific R+D software,4.839,4.254,109,476,
2.4) Otros productos de propiedad intelectual específicos para I+D,8.203,7.271,286,647,
1.1) By origin of the funds: Own funds,613.097,418.567,47.014,147.516,
1.2) By origin of the funds: From companies,86.085,44.282,10.408,31.395,
1.3) By origin of the funds: Public Administration funds,92.140,56.901,11.393,23.846,
1.4) By origin of the funds: From Universities,853,519,0,335,
1.5) By origin of the funds: From non profit private institutions,4.682,1.965,0,2.717,
1.6) By origin of the funds: Foreign funds,100.476,80.287,8.786,11.403,
Purchase of R&D services in biotechnology (thousands of euros),85.011,62.516,14.617,7.878,
Purchase of R&D services in biotechnology (thousands of euros): In Spain,54.243,36.965,11.023,6.255,
Purchase of R&D services in biotechnology (thousands of euros): Abroad,30.768,25.552,3.594,1.622,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to capital,39,2,48,3,36,5,27,7,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information,11,7,10,9,15,3,11,4,
%Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources,12,5,12,7,12,8,12,1,
%Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain,10,9,12,9,4,9,9,
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of access to international markets,14,16,14,12,
%Companies that consider the following obstacles as very important considering biotechnology development : Lack of distribution and sales channels,17,21,15,11,
%Companies that consider the following obstacles as very important considering biotechnology development : Acceptance / public perception,15,16,15,14,
%Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements,36,42,35,27,
%Companies that consider the following obstacles as very important considering biotechnology development : Time / cost,47,53,44,39,
%Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting,19,21,8,17,6,15,6,
% Companies that have requested biotechnology patents,17,25,16,7,
Number of patents requested,681,473,65,144,
% Companies with income of an international origin related to biotechnological activities,23,28,9,17,9,17,
% Turnover representing income of an international origin related to biotechnological activities,1,6,9,4,0,1,0,6,
% Income of of an international origin related to biotechnological activities distributed in: Income received from the EU,56,56,74,49,
% Income of of an international origin related to biotechnological activities distributed in: Income received from other countries,44,44,26,51,
% Income of of an international origin related to biotechnological activities by classification: Internacional trade in products and services,84,82,82,96,
% Income of an international origin related to biotechnological activities by classification: Milestones, royalties, sale or licensing of technologies outside Spain,14,7,17,1,2,0,4,
% Income of an international origin related with activities according to the classification: Operating source abroad,0,8,0,2,15,5,1,6,
% Income of an international origin related with activities according to the classification: Other,0,6,0,5,0,2,1,5,
Notas:
'.'=numeric piece of data equal to zero not resulting from rounding 

 FTE: Full Time Equivalent
Fuente: National Statistics Institute